A Natural Product YSK-A Blocks SARS-CoV-2 Propagation by Targeting Multiple Host Genes

Overview

Journal Sci Rep

Specialty Science

Date 2023 Dec 6

PMID 38057373

Authors

Thuy X Pham

Trang T X Huynh

Bumseok Kim

Yun-Sook Lim

Soon B Hwang

Affiliations

Soon will be listed here.

Abstract

Natural products and herbal medicine have been widely used in drug discovery for treating infectious diseases. Recent outbreak of COVID-19 requires various therapeutic strategies. Here, we used YSK-A, a mixture of three herbal components Boswellia serrata, Commiphora myrrha, and propolis, to evaluate potential antiviral activity against SARS-CoV-2. We showed that YSK-A inhibited SARS-CoV-2 propagation with an IC values of 12.5 µg/ml and 15.42 µg/ml in Vero E6 and Calu-3 cells, respectively. Using transcriptome analysis, we further demonstrated that YSK-A modulated various host gene expressions in Calu-3 cells. Among these, we selected 9 antiviral- or immune-related host genes for further study. By siRNA-mediated knockdown experiment, we verified that MUC5AC, LIF, CEACAM1, and GDF15 host genes were involved in antiviral activity of YSK-A. Therefore, silencing of these genes nullified YSK-A-mediated inhibition of SARS-CoV-2 propagation. These data indicate that YSK-A displays an anti-SARS-CoV-2 activity by targeting multiple antiviral genes. Although the exact antiviral mechanism of each constituent has not been verified yet, our data indicate that YSK-A has an immunomodulatory effect on SARS-CoV-2 and thus it may represent a novel natural product-derived therapeutic agent for treating COVID-19.

Citing Articles

Insights into frankincense and myrrh research: A comprehensive analytical study of patterns and perspectives.

Abdelwahab S, Taha M, Jerah A, Farasani A, Abdullah S, Aljahdali I Heliyon. 2024; 10(19):e38102.

PMID: 39416835 PMC: 11481677. DOI: 10.1016/j.heliyon.2024.e38102.

References

Lee H, Yum J, Rho Y, Oh S, Choi H, Chang H . Inhibition of HCV replicon cell growth by 2-arylbenzofuran derivatives isolated from Mori Cortex Radicis. Planta Med. 2007; 73(14):1481-5. DOI: 10.1055/s-2007-990249. View

Rochette L, Dogon G, Rigal E, Zeller M, Vergely C, Cottin Y . GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19. Ann Cardiol Angeiol (Paris). 2022; 72(1):41-43. PMC: 9477966. DOI: 10.1016/j.ancard.2022.09.001. View

Danziger O, Patel R, DeGrace E, Rosen M, Rosenberg B . Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor. PLoS Pathog. 2022; 18(4):e1010464. PMC: 9041830. DOI: 10.1371/journal.ppat.1010464. View

Babalghith A, Al-Kuraishy H, Al-Gareeb A, De Waard M, Sabatier J, Saad H . The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?. Diagnostics (Basel). 2022; 12(9). PMC: 9497461. DOI: 10.3390/diagnostics12092051. View

Li B, Dewey C . RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011; 12:323. PMC: 3163565. DOI: 10.1186/1471-2105-12-323. View

Sayed A, Khattab A, AboulMagd A, Hassan H, Rateb M, Zaid H . Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale. RSC Adv. 2022; 10(34):19790-19802. PMC: 9122629. DOI: 10.1039/d0ra04199h. View

Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Al Heialy S, Alsafar H, Hamoudi R . Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection. Mol Ther Methods Clin Dev. 2020; 20:109-121. PMC: 7658590. DOI: 10.1016/j.omtm.2020.11.002. View

Karki R, Sharma B, Tuladhar S, Williams E, Zalduondo L, Samir P . Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 2020; 184(1):149-168.e17. PMC: 7674074. DOI: 10.1016/j.cell.2020.11.025. View

Zhao B, Li H, Cao S, Zhong W, Li B, Jia W . Negative Regulators of Inflammation Response to the Dynamic Expression of Cytokines in DF-1 and MDCK Cells Infected by Avian Influenza Viruses. Inflammation. 2021; 45(2):573-589. DOI: 10.1007/s10753-021-01568-y. View

10.

Foronjy R, Dabo A, Cummins N, Geraghty P . Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection. BMC Immunol. 2014; 15:41. PMC: 4189665. DOI: 10.1186/s12865-014-0041-4. View

11.

Furutani Y, Toguchi M, Higuchi S, Yanaka K, Gailhouste L, Qin X . Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α. Int J Mol Sci. 2021; 22(21). PMC: 8583800. DOI: 10.3390/ijms222111641. View

12.

Kozaki T, Komano J, Kanbayashi D, Takahama M, Misawa T, Satoh T . Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response. Proc Natl Acad Sci U S A. 2017; 114(10):2681-2686. PMC: 5347618. DOI: 10.1073/pnas.1621508114. View

13.

Scorza C, Goncalves V, Scorza F, Fiorini A, de Almeida A, Fonseca M . Propolis and coronavirus disease 2019 (COVID-19): Lessons from nature. Complement Ther Clin Pract. 2020; 41:101227. PMC: 7415165. DOI: 10.1016/j.ctcp.2020.101227. View

14.

Berretta A, Duarte Silveira M, Condor Capcha J, de Jong D . Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother. 2020; 131:110622. PMC: 7430291. DOI: 10.1016/j.biopha.2020.110622. View

15.

Stadler D, Kachele M, Jones A, Hess J, Urban C, Schneider J . Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20. EMBO Rep. 2021; 22(6):e49568. PMC: 8183418. DOI: 10.15252/embr.201949568. View

16.

Yamada T, Horimoto H, Kameyama T, Hayakawa S, Yamato H, Dazai M . Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense. Nat Immunol. 2016; 17(6):687-94. DOI: 10.1038/ni.3422. View

17.

Siddiqui M . Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2012; 73(3):255-61. PMC: 3309643. DOI: 10.4103/0250-474X.93507. View

18.

Qu H, Li J, Yang L, Sun L, Liu W, He H . Influenza A Virus-induced expression of ISG20 inhibits viral replication by interacting with nucleoprotein. Virus Genes. 2016; 52(6):759-767. DOI: 10.1007/s11262-016-1366-2. View

19.

Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo Jr C, Liang L . Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020; 146(2):327-329.e4. PMC: 7423602. DOI: 10.1016/j.jaci.2020.06.001. View

20.

Li G, Hilgenfeld R, Whitley R, De Clercq E . Therapeutic strategies for COVID-19: progress and lessons learned. Nat Rev Drug Discov. 2023; 22(6):449-475. PMC: 10113999. DOI: 10.1038/s41573-023-00672-y. View